Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small integral membrane protein 10-like protein 1 (SMIM10L1) is a predicted membrane-associated protein with an α-helical structure that plays a role in regulating adipogenesis. Its downregulation promotes differentiation of adipose progenitor cells and is associated with increased PI3K/AKT/mTOR signaling and upregulation of the adipogenic transcription factor SREBP1. This suggests a possible role in adipose tissue biology and a potential contribution to lipoma formation, particularly in the context of PTEN Hamartoma Tumor Syndrome (PHTS). The gene is protein-coding, and while its full range of biological and disease associations remains incompletely understood, current evidence supports a function in adipose cell biology rather than direct action as a classical therapeutic target such as a receptor, enzyme, transporter, or ion channel[1][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small integral membrane protein 10-like protein 1 (SMIM10L1).